Clinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus

Mycobacterium massiliense has been recognized as a separate species from Mycobacterium abscessus; however, little is known regarding the clinical impact of this differentiation. To compare clinical features and treatment outcomes between patients with M. abscessus lung disease and those with M. mass...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of respiratory and critical care medicine 2011-02, Vol.183 (3), p.405-410
Hauptverfasser:	KOH, Won-Jung, JEON, Kyeongman, DALEY, Charles L, JUNG KWON, O, NAM YONG LEE, KIM, Bum-Joon, KOOK, Yoon-Hoh, LEE, Seung-Heon, YOUNG KIL PARK, CHANG KI KIM, SUNG JAE SHIN, HUITT, Gwen A
Format:	Artikel
Sprache:	eng
Schlagworte:	Amikacin - therapeutic use Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antibiotics Antibiotics, Antitubercular - therapeutic use Biological and medical sciences Cefoxitin - therapeutic use Clarithromycin - therapeutic use Clinical outcomes Drug Resistance, Bacterial Drug Therapy, Combination Emergency and intensive care: metabolism and nutrition disorders. Enteral and parenteral nutrition Female Humans Infections Intensive care medicine Lung diseases Male Medical sciences Microbial Sensitivity Tests Middle Aged Mycobacterium Infections, Nontuberculous - diagnosis Mycobacterium Infections, Nontuberculous - drug therapy Mycobacterium Infections, Nontuberculous - microbiology Nontuberculous Mycobacteria - drug effects Pathogens Response rates Retrospective Studies Sputum - microbiology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!